Elcosten Capsule (Erstostein)

Adult dose

Adults: Administer 300 mg of erdosteine orally 2~3 times daily. When used to treat acute respiratory conditions, do not administer continuously for more than 10 days.

This medication should not be used in certain patients. It should not be administered to patients with an allergy to this drug or its components. Patients with liver cirrhosis or certain enzyme deficiencies should avoid this medication as its metabolites may interfere with methionine metabolism in the body. Patients with peptic ulcers should also avoid this medication as it may exacerbate symptoms. Patients with severe renal impairment or severe hepatic impairment should not be given this medication as it may put a burden on the body. There are also patients who require caution when using this medication. Patients with mild to moderate hepatic impairment should be careful not to exceed 300 mg per day when taking this medication. This medication contains a pigment called Tartrazine, so patients who have an allergy or hypersensitivity to this component should use it cautiously. In case of overdose, symptoms such as sweating, dizziness, and flushing may occur. Neurological and respiratory symptoms like headache, cold symptoms, and dyspnea have also been reported. Digestive system symptoms may include taste disturbances, nausea, vomiting, diarrhea, abdominal pain, and heartburn. Skin reactions such as urticaria, erythema, and eczema may occur, requiring attention. In post-market surveillance in South Korea, various adverse reactions, including fatigue, indigestion, facial swelling, and itching, have been reported, but their association with this drug is not clearly established. When taken with expectorants, this drug may make the expulsion of phlegm from the bronchi more difficult due to cough relief, which may increase the risk of bronchial infections or cause bronchial spasms, so caution is necessary when combined. Women who are pregnant or breastfeeding should avoid taking this medication as its safety has not been established. No special toxicity was found in animal experiments; however, for safety reasons, women who are likely to become pregnant, pregnant, or nursing should avoid its use. This medication should be kept out of the reach of children, and transferring it to another container may pose a risk of accidents and may not maintain the drug's quality, so it is safe to store it in its original container.

• sweating
• dizziness
• flushing
• headache
• cold
• shortness of breath
• altered taste
• nausea
• vomiting
• diarrhea

Drug interactions

Consult with a physician or pharmacist if taking this drug in conjunction with cough medication.

This drug must be stored in a tightly sealed container to protect it from exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. This helps to preserve the drug's efficacy and safety.

Appearance

A hard capsule with green upper part and yellow lower part containing white to milky white powder

Package unit

30 capsules/bottle, 300 capsules/bottle